Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03651752 · ClinicalTrials.gov registry record · Phase 3
DPCP for the Treatment of Alopecia Areata
A Phase 3 study, sponsored by University of Minnesota.
- Terminated
- Registry status
- Phase 3
- Development phase
- 4
- Enrollment target
NCT03651752 is a Phase 3 study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 4 participants.
The verdict
NCT03651752, a Phase 3 study, was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 4 participants
- Enrollment target
Study Summary
This is an open labeled study to determine the response and characteristics, safety and efficacy, of the proprietary DPCP ointment composition as a topical immunotherapeutic agent for the treatment of extensive alopecia areata.
Interventions
- DRUG Diphenylcyclopropenone (DPCP) Ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2024-09-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03651752
The ClinicalTrials.gov registry entry for NCT03651752 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diphenylcyclopropenone (DPCP) Ointment is the first listed.
NCT03651752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03651752 about?
NCT03651752 is a clinical study titled "DPCP for the Treatment of Alopecia Areata". This is an open labeled study to determine the response and characteristics, safety and efficacy, of the proprietary DPCP ointment composition as a topical immunotherapeutic agent for the treatment of extensive alopecia areata.
What is the current status of trial NCT03651752?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 4 participants. The study started on 2024-04-01. Estimated completion is 2024-09-01.
What interventions are being tested in trial NCT03651752?
The interventions under investigation include: Diphenylcyclopropenone (DPCP) Ointment (DRUG).
Who is sponsoring clinical trial NCT03651752?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.